De­ci­phera had an­oth­er bid­der be­fore Ono deal; Bris­tol My­ers re­ports Ph3 fail in lung can­cer

Plus, news about OnKure:

De­ci­phera’s oth­er bid­der: Be­fore its ac­qui­si­tion by Ono Phar­ma­ceu­ti­cal, De­ci­phera had one oth­er bid­der that of­fered $19.00 per share, ac­cord­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER